(NEW YORK) — The rollout of updated COVID-19 vaccines is just around the corner, but there's growing concern about accessibility for some Americans, especially those without health insurance. The Centers for Disease Control and Prevention (CDC) previously operated the Bridge Access Program, aiding uninsured adults by providing free COVID-19 vaccines as part of public-private efforts. Unfortunately, due to cuts in federal funding, this program is set to end, leaving millions vulnerable.
Currently, people covered by Medicare, Medicaid, or private insurance still have the assurance of receiving the updated vaccines at no cost. But for the estimated 25 to 30 million adults who lack insurance, the impending reality is stark: they will have to pay out of pocket for their shots. Dr. Nathaniel Hupert, associate professor at Weill Cornell Medical College, pointed out the unfortunate timing of the program’s end. “We don’t yet have the 2024-25 versions of the COVID shots readily available, so the Bridge program will conclude before those are accessible to uninsured individuals,” he stated.
To combat this, the CDC has designated $62 million from unused vaccine contract funds to assist state and local health departments with purchasing vaccines for those who are uninsured or underinsured. Yet, many experts caution this amount may not be nearly enough. Dr. Rebecca Weintraub from Harvard Medical School emphasized, “While $62 million might seem like a lot, state and local health departments are already stretched thin since the pandemic; they simply don't have the cash reserves to manage upfront payments for such expensive vaccines.”
Heading to Mecklenburg County, North Carolina, where public health director Dr. Raynard Washington spoke about the struggle to procure enough updated vaccines. With around 100,000 residents aged 19 to 64 uninsured, he stated, “Even if 10% of those adults wanted or needed to receive a vaccine, we’re talking several hundred thousand dollars—a cost we simply can’t assume.” Although some COVID funds may be available to cover administrative costs, the county is not equipped to foot the entire bill for the vaccines.
Vaccine pricing remains another barrier. Last year, Pfizer and Moderna pegged the commercial price for their COVID-19 vaccine doses between $110 and $130 each, and it’s likely those prices might increase this year. Dr. Washington warns these costs present massive financial challenges for many uninsured Americans, compelling them to make tough choices between healthcare and other basic needs.
Despite the mounting obstacles, experts assert the significance of vaccines remains undiminished. "Vaccines are still the most effective safeguards available against severe illness or hospitalization from COVID-19,” Dr. Washington articulated, urging particularly vulnerable populations, including adults and children with preexisting health issues, to stay informed about vaccination opportunities.
For those without adequate vaccine coverage, there exists community programs aimed at children. The federally funded Vaccines for Children Program ensures low-income families can access necessary vaccinations at no cost. Public health advocates are now calling for similar initiatives to be established for adults. “A Vaccine for Adults Program could go a long way,” they suggest, alongside proposals for pharmacy discount programs to lessen the financial strain on low-income or uninsured individuals.
Meanwhile, the narrative shifts to the Bay Area, where updated vaccines targeting recently dominant FLiRT variants have begun arriving. CVS pharmacies are already loaded with the updated shots, as seen at the Berkeley location. “All of our patients are eager for the new vaccine—every day, we’re getting questions about it. They’ve been waiting for this,” stated James Lee, the CVS Pharmacy District Leader.
Positive reports are rolling in as well. Early recipients like Pascal Kouromenos shared their experiences, saying, “So far so good, no reaction.” Most recently approved by the FDA, the newer vaccines are seen not just as optional but as necessary, particularly with unsettlingly high COVID-19 wastewater levels reported throughout California. These alarming figures serve as reminders of the disease still thriving and impacting many vulnerable populations.
The perspectives of health professionals such as UCSF’s Dr. James Lee weigh heavily on the conversation, especially when it concerns cancer patients or those with weakened immune systems. Dr. Lee suggests timing the vaccine as closely as possible to chemotherapy treatment, “This allows them to combat the virus more effectively when their immune systems are prepared.”
The encouraging words of newly vaccinated individuals, also, are calling for others to reconsider their stance. “You could get COVID and lung infections and all kinds of complications. It’s best we all get immunized,” urged Susan Kleinstein, who also received her updated shot.
The latest efforts to roll out the vaccines come amid disturbing trends: as of May, only just over 22% of American adults had opted for the most recent shot, marking a steep drop from 85% just two years ago. Although many have moved on from the pandemic mentality, health officials are working tirelessly to remind the population of the high stakes still involved and potential future outbreaks.
It’s clear this fall vaccine rollout is not just about new shots; it’s about uniting communities, ensuring patients can access what they need, and confronting obstacles head-on. Vaccine distribution, affordability, and community awareness will play pivotal roles as America navigates this next phase of the pandemic.
Copyright © 2024, ABC Audio. All rights reserved.
